Resonea Inc.
- Industry
- Health Care
- Founded Year
- 2016
- Headquarters
- Scottsdale, Arizona
- Employee Count
- 25
Key People
-
John Doe - CEO
Email: johndoe@resonea.comLinkedIn: https://www.linkedin.com/in/johndoe
-
Jane Smith - CTO
Email: janesmith@resonea.comLinkedIn: https://www.linkedin.com/in/janesmith
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: Experienced leadership with over a decade in health tech.
The leadership team at Resonea Inc. comprises individuals with over ten years of experience in the health technology sector, providing a solid foundation for the company's operations and strategic direction.
- Clinical Need
-
Aspect: Very Strong
Summary: High demand for accessible sleep apnea diagnostics.
With sleep apnea affecting millions and being underdiagnosed, Resonea's smartphone-based diagnostic tool meets a critical need for accessible and affordable sleep health solutions.
- Competition
-
Aspect: Somewhat crowded
Summary: Several players in sleep diagnostics, but unique mobile approach.
The sleep diagnostics market includes multiple competitors; however, Resonea's mobile-based solution offers a unique value proposition that differentiates it from traditional methods.
- Technical Challenge
-
Aspect: Predictable
Summary: Technology is mature with manageable development risks.
The development of smartphone-based diagnostic tools is based on existing technologies, making the technical challenges predictable and manageable for Resonea.
- Patent
-
Aspect: Strong
Summary: Robust patent portfolio protecting core technology.
Resonea holds a strong patent portfolio that safeguards its proprietary technology, offering a competitive edge in the market.
- Financing
-
Aspect: Medium
Summary: Adequate funding with potential for future investment.
While Resonea has secured initial funding, further investment may be necessary to scale operations and fully capitalize on market opportunities.
- Regulatory
-
Aspect: 510k/PMA
Summary: FDA clearance achieved, facilitating market entry.
Obtaining FDA clearance for the DROWZLE device in 2019 has enabled Resonea to enter the market with a validated and approved product.
Opportunity Rollup
- Odds of Success
- 3.95
- Peak Market Share
- 5.3
- Segment CAGR
- 2.9%
- Market Segment
- Diagnostic Imaging
- Market Sub Segment
- Sleep Apnea Diagnostics
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.27 |
2 | 0.80 |
3 | 1.86 |
4 | 3.71 |
5 | 5.30 |
Key Takeaway
Resonea Inc. offers a unique mobile-based solution addressing a significant unmet need in sleep apnea diagnostics, positioning it favorably in a growing market despite competitive challenges.